Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Pham, Lan V.
3762  Ergebnisse:
Personensuche X
?
1

The synergy of the XPO1 inhibitors combined with the BET in..:

Deng, Manman ; Tan, Jinshui ; Fan, Ziying...
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
2

CS2164 and Venetoclax Show Synergistic Antitumoral Activiti..:

Yuan, Delin ; Li, Genhong ; Yu, Lian...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
3

XPO1 expression worsens the prognosis of unfavorable DLBCL ..:

Deng, Manman ; Zhang, Mingzhi ; Xu-Monette, Zijun Y....
Journal of Hematology & Oncology.  13 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
4

Rational Targeted Therapeutics for Double-Hit Lymphoma:

Azizian, Nancy G ; Liu, Yuanhui ; Pham, Lan V.
International Journal of Hematologic Oncology.  8 (2019)  3 - p. , 2019
Link: https://doi.org/10.2217/..
 
?
5

Interleukin-1 receptor associated kinase (IRAK)-M -mediated..:

Liu, Baozhu ; Gu, Yong ; Pei, Shanshan...
Journal of Autoimmunity.  102 (2019)  - p. 77-88 , 2019
Link: https://doi.org/10.1016/..
 
?
6

Simultaneous targeting of XPO1 and BCL2 as an effective tre..:

Liu, Yuanhui ; Azizian, Nancy G. ; Dou, Yaling..
Journal of Hematology & Oncology.  12 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
7

The Role of Macrophage/B-Cell Interactions in the Pathophys..:

Pham, Lan V. ; Pogue, Elizabeth ; Ford, Richard J.
Frontiers in Oncology.  8 (2018)  - p. , 2018
Link: https://doi.org/10.3389/..
 
?
8

Preclinical efficacy and biological effects of the oral pro..:

Liu, Wei ; Chen, Juan ; Tamayo, Archito T....
Oncotarget.  9 (2017)  1 - p. 346-360 , 2017
Link: https://doi.org/10.18632..
 
?
9

CCND1 mutations increase protein stability and promote ibru..:

Mohanty, Atish ; Sandoval, Natalie ; Das, Manasi...
Oncotarget.  7 (2016)  45 - p. 73558-73572 , 2016
Link: https://doi.org/10.18632..
 
?
10

RelA NF-κB subunit activation as a therapeutic target in di..:

Zhang, Mingzhi ; Xu-Monette, Zijun Y. ; Li, Ling...
Aging.  8 (2016)  12 - p. 3321-3340 , 2016
Link: https://doi.org/10.18632..
 
?
11

Targeting the hexosamine biosynthetic pathway and O-linked ..:

Pham, Lan V. ; Bryant, Jerry L. ; Mendez, Richard...
Oncotarget.  7 (2016)  49 - p. 80599-80611 , 2016
Link: https://doi.org/10.18632..
 
?
12

Establishment and characterization of a novel MYC/BCL2 "dou..:

Pham, Lan V. ; Lu, Gary ; Tamayo, Archito T....
Journal of Hematology & Oncology.  8 (2015)  1 - p. , 2015
Link: https://doi.org/10.1186/..
 
?
13

Prognostic impact of c-Rel nuclear expression andRELamplifi..:

Li, Ling ; Xu-Monette, Zijun Y. ; Ok, Chi Young...
Oncotarget.  6 (2015)  27 - p. 23157-23180 , 2015
Link: https://doi.org/10.18632..
 
?
14

Novel selective inhibitors of nuclear export CRM1 antagonis..:

Zhang, Kejie ; Wang, Michael ; Tamayo, Archito T....
Experimental Hematology.  41 (2013)  1 - p. 67-78.e4 , 2013
Link: https://doi.org/10.1016/..
 
?
15

Over-expression of Thioredoxin-1 mediates growth, survival,..:

Li, Changping ; Thompson, Michael A. ; Tamayo, Archito T....
Oncotarget.  3 (2012)  3 - p. 314-326 , 2012
Link: https://doi.org/10.18632..
 
1-15